Navigation Links
Pitt Cancer Institute finds new targets for drugs to defeat aggressive brain tumor
Date:12/14/2012

PITTSBURGH, Dec. 13, 2012 University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy the cancer cells.

The results will be reported in the cover story of December's issue of the journal Molecular Cancer Research, to be published Dec. 18 and currently available online.

The potential drug targets were identified after testing more than 5,000 genes derived from glioblastoma multiforme, an aggressive brain tumor. The genes were evaluated for their role in responding to the chemotherapy drug temozolomide.

"The current standard of care for people with this type of cancer is to remove as much of the tumor as possible, and then treat with radiation and temozolomide," said lead author David Svilar, Ph.D., a student in the Medical Scientist Training Program at the University of Pittsburgh School of Medicine. "However, glioblastoma multiforme is highly resistant to this chemotherapy drug, so we need to find better treatments to improve the patient survival rate."

According to the National Cancer Institute, glioblastoma multiforme is the most common type of brain tumor in adults. It accounts for about 15 percent of all brain tumors, and typically occurs in people between the ages of 45 and 70 years.

Patients with glioblastoma multiforme usually survive less than 15 months after diagnosis, and there are no effective long-term treatments for the disease.

Temozolomide, also known by the brand name Temodar, works by modifying the cancer's DNA in a way that triggers cell death. It has been approved by the U.S. Food and Drug Administration for use in brain tumors and is in clinical trials for other cancers, such as melanoma and leukemia. It is well-tolerated in most patients.

"Unfortunately, some cancers - particularly glioblastoma multiforme are able to repair the DNA damage done to the tumor by Temozolomide before the cancer cells are destroyed," said senior author Robert W. Sobol, Ph.D., a scientist at UPCI and an associate professor in the departments of Pharmacology & Chemical Biology and Human Genetics. "Clinical trials are underway to test drugs and chemotherapy dosing schedules to inhibit this repair, but none have proven effective to date."

Dr. Sobol and his colleagues identified multiple "druggable" targets that could make the cancer more sensitive to temozolomide, as well as the processes that allow the tumor to survive the onslaught of surgery, radiation and chemotherapy.

"Our hope is that drug companies will use our findings to develop adjuvant chemotherapy drugs that will vastly improve patient survival from this deadly cancer," said Dr. Sobol.


'/>"/>

Contact: Allison Hydzik
HydzikAM@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer and teacher ... Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat with world ... and spiritual journey during the Summer Solstice will also be her final international ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... are now offering treatments for sleep apnea and TMJ at their office. TMJ, ... apnea , specifically the obstructive type, is increasingly being treated at dental offices ...
(Date:3/24/2017)... ... ... who like to educate themselves on current issues and who enjoy gaining knowledge on ... to appreciate and love the "Informed" series, hosted by Rob Lowe. A new ... the world. , Running for charity has become a multi-million dollar enterprise ...
(Date:3/24/2017)... ... 2017 , ... Judy Buchanan, co-owner of Serenity Natural Health ... says, “I am passionate about sharing Reiki as a holistic, complementary therapy with ... time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical Reiki™ ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “Vintage and Harvest ... retired minister and college Bible teacher residing in North Carolina with his wife, Anna ... have blessed them with six grandchildren. David is also the author of “Shadow and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar 24, 2017 The Board of ... company,s Annual Report 2016 including the complete 2016 Annual Accounts ... available on Nordic Nanovector,s website in the section Investor Relations/Reports ... ... enquiries: Tone Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ...
(Date:3/23/2017)... Ala. , March 23, 2017 Mosaic Life Care, based in ... the patient registration process across its network of 58 clinics, located in 22 cities, ... seeking new and innovative ways to improve the delivery of health care to its ... Continue Reading ... Mosaic Life Care St. Joseph Medical ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market: Analysis By Procedure, Replacement Procedure By Technique, Repair Procedure By ... ... Valve Devices Market is forecasted to grow at a CAGR of ... devices is driven by rising aging population, growth in population with ...
Breaking Medicine Technology: